Artificial intelligence to improve cytology performance in urothelial carcinoma diagnosis: results from validation phase of the French, multicenter, prospective VISIOCYT1 trial - Poll - MDSpire

Artificial intelligence to improve cytology performance in urothelial carcinoma diagnosis: results from validation phase of the French, multicenter, prospective VISIOCYT1 trial

  • By

  • Thierry Lebret

  • Xavier Paoletti

  • Geraldine Pignot

  • Mathieu Roumiguié

  • Marc Colombel

  • Laurent Savareux

  • Grégory Verhoest

  • Laurent Guy

  • Jérome Rigaud

  • Stéphane De Vergie

  • Grégoire Poinas

  • Stéphane Droupy

  • François Kleinclauss

  • Monique Courtade-Saïdi

  • Eric Piaton

  • Camelia Radulescu

  • Nathalie Rioux-Leclercq

  • Christine Kandel-Aznar

  • Karine Renaudin

  • Béatrix Cochand-Priollet

  • Yves Allory

  • Sébastien Nivet

  • Morgan Rouprêt

  • July 22, 2023

  • 0 min

Share

Original Source(s)

Artificial intelligence to improve cytology performance in urothelial carcinoma diagnosis: results from validation phase of the French, multicenter, prospective VISIOCYT1 trial

  • by Thierry Lebret, Xavier Paoletti, Geraldine Pignot, Mathieu Roumiguié, Marc Colombel, Laurent Savareux, Grégory Verhoest, Laurent Guy, Jérome Rigaud, Stéphane De Vergie, Grégoire Poinas, Stéphane Droupy, François Kleinclauss, Monique Courtade-Saïdi, Eric Piaton, Camelia Radulescu, Nathalie Rioux-Leclercq, Christine Kandel-Aznar, Karine Renaudin, Béatrix Cochand-Priollet, Yves Allory, Sébastien Nivet, Morgan Rouprêt

  • July 22, 2023

Related Content

Pan-segmental intraprostatic lesions involving mid-gland and apex of prostate (mid-apical lesions): assessing the true value of extreme apical biopsy cores

Confocal laser endomicroscopy for upper tract urothelial carcinoma: validation of the proposed criteria and proposal of a scoring system for real-time tumor grading

Residual stone fragments: systematic review of definitions, diagnostic standards